Baker Brothers Life Sciences Capital (GP), LLC.

Recent transactions

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

1. SEATTLE GENETICS INC /WA14,638,126reported25 Aug 2011
   tx 53+ 10,135,051− 1,087,305
2. INCYTE CORP11,415,068reported07 Dec 2011
   tx 50+ 57,768,982
3. GENOMIC HEALTH INC8,213,837reported05 Mar 2012
   tx 62+ 2,436,246
4. VIROPHARMA INC7,979,055reported10 Aug 2011
   tx 13+ 2,265,627
5. PHARMACYCLICS INC7,955,222reported23 Jan 2012
   tx 19+ 712,885− 249
6. ADOLOR CORP6,669,338reported30 Jun 2011
   tx 13+ 341,509
7. AUXILIUM PHARMACEUTICALS INC6,105,365reported29 Mar 2011
   tx 14+ 1,450,784
8. ALLOS THERAPEUTICS INC5,771,961reported06 Feb 2009
   tx 13+ 29,401− 2,230,815
9. INTRABIOTICS PHARMACEUTICALS INC /DE4,045,398reported30 Jun 2011
   tx 11+ 1,977,069− 331,517
10. BIOCRYST PHARMACEUTICALS INC3,874,348reported01 Jun 2009
    tx 6− 516,932